close
MENU
How to guide
How to guide
Home
The NBR Rich List
NBR Marketplace
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Marketing & Media Tourism Energy Luxury Property Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

NBR Marketplace Local Edge NBR Video Toil & Trouble Beehive Banter Morning Brew Dollars & Sense Entrepreneurs The Grind Market Outlook Executive Health Market Review Students’ Say The NBR Podcast Opinion (Archive) NBR Radar (Archive) Private Bin NZ Aviation News (Archive) NBR Rich List (Archive) Your Business Audio Articles The NBR Rich List
Latest
Related
Investment
12

FMA warns investors to be ‘fully informed’ on Whimp’s offers
Finance
10

FMA’s Whimp investigation appears warranted, says legal expert
Finance
48

Just-retired bricklayer ponders loss of $350,000 in Whimp company
General Business
13

FMA investigates Bernard Whimp, puts companies into liquidation

Shoeshine
13

Bernard Whimp is back: old dog, new tricks?

Shoeshine
1

Sure to rise: can new My Food Bag CEO deliver?

ANALYSIS: Kevin Bowler’s unexpected resignation as CEO last month gives much-maligned company a golden opportunity.

Hamish McNicol Mon, 10 Oct 2022
Shoeshine
5

Is Southern Cross squeezing the lemon too hard on fees?

ANALYSIS: One medical provider speaks out; Southern Cross says it’s no bully.

Fiona Rotherham Mon, 03 Oct 2022
Shoeshine
2

Supermarkets benevolently swallow the cost of inflation

ANALYSIS: Or do they? Supermarkets and suppliers locked in battle of wits.

Dita De Boni Tue, 27 Sep 2022
Shoeshine
3

Homegrown pharmaceutical firm takes long view

ANALYSIS: Let Douglas Pharmaceuticals not be an outlier in New Zealand’s promising health tech sector.

Maria Slade Mon, 19 Sep 2022
Shoeshine

Earnings season beats expectations but worst is yet to come

ANALYSIS: Headwinds as strong as ever despite listed companies reporting generally positive financial results.

Hamish McNicol Mon, 12 Sep 2022
Shoeshine

The new broom at global health IT provider Orion Health

ANALYSIS: ‘As I say to them, don’t mess it up,’ says founder and former CEO Ian McCrae.

Fiona Rotherham Mon, 05 Sep 2022
Shoeshine

Who are the Edmund Hillary Fellows?

Scheme to boost New Zealand’s entrepreneurial vitality welcomes latest cohort of recruits.

Will Mace Mon, 29 Aug 2022
Shoeshine
5

Another one gets away from the NZX

Partners Life's massive $1b sale should be celebrated, but has left some wondering what could have been.

Hamish McNicol Mon, 22 Aug 2022
Shoeshine
10

Heads bang on desks over builders guarantees

ANALYSIS: Bloody-minded officials put kibosh yet again on mandatory new-build warranties.

Maria Slade Mon, 15 Aug 2022
1 16 17 18 19 20 58
Most Popular
Most Commented
Guest Analysis

Why geopolitics is changing the investment landscape
Book Review

Uzbekistan’s Silk Road is paved with gold

Weekly Wrap: Kiwi tourism, Whimp’s ‘punch-up’, back to the ’90s.
Retail
1

Allbirds to shutter all full-price US stores

General Business

Nick Mills liquidates companies after IRD comes knocking, again
General Business
2

Watch this space: new Giltrap division sales exceed expectations
Edwards on Politics
24

Lessons Nicola Willis might learn from the 2023 Budget
General Business
18

Former Chance Voight staff clash with Whimp over wages

Shoeshine
15

Whimp warns of pending punch-up with FMA over company collapse
Investment
6

NZX’s wish list of tax changes to boost capital markets
Politics
5

Bi-partisan agreement on Modern Slavery Bill
Investment
4

Santana shares hit amid concern over consent timeframe
Subscribe Login